Syndax Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting
Mar 29, 2017 11:00 am UTC| Business
WALTHAM, Mass., March 29, 2017 -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company focused on developing entinostat and SNDX-6352 in multiple...
Cempra to Present at the 16th Annual Needham & Company Healthcare Conference
Mar 29, 2017 11:00 am UTC| Business
CHAPEL HILL, N.C., March 29, 2017 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and community settings to meet critical...
Leap Therapeutics to Present at Two Investor Conferences in April
Mar 29, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., March 29, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Recro Pharma to Present at the 16th Annual Needham Healthcare Conference
Mar 29, 2017 11:00 am UTC| Business
MALVERN, Pa., March 29, 2017 -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced that Gerri...
BioCryst to Present at the 16th Annual Needham Healthcare Conference
Mar 29, 2017 10:52 am UTC| Business
RESEARCH TRIANGLE PARK, N.C., March 29, 2017 -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate update regarding the Company’s clinical...
Mar 29, 2017 10:45 am UTC| Business
WEST PALM BEACH, Fla., March 29, 2017 -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, recognized exemplary customers and partners with...
Mar 29, 2017 10:30 am UTC| Business
CAMBRIDGE, Mass., March 29, 2017 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that new preclinical data on tazemetostat, Epizyme’s lead...